In the Arrest, Who You Gonna Call? Clot Busters?

Posted on May 23, 2023
Dr. Rech and Lovett

Speakers:
Megan A Rech, PharmD, MS, FCCM, FCCP, BCCCP
Emergency Medicine Clinical Pharmacist
PGY-2 Critical Care Pharmacy Residency Director
Affiliate Assistant Professor – Department of Emergency Medicine
Research Director – Department of Emergency Medicine
Stritch School of Medicine, Loyola University Chicago
Loyola University Medical Center

and

Shannon Lovett, MD, FACEP
Associate Professor
Associate Medical Director, ED Clinical Operations
Department of Emergency Medicine
Stritch School of Medicine

An Application-Based Activity
ACPE UAN # 0016-0000-23-034-L01-P, 1.0 contact hour, 1.0 AMA PRA Category 1 Credit(s)™ CME, 1.0 contact hour CNE

Learning Objectives:

  • Discuss the advantages to use and literature supporting thrombolytics in the setting of cardiac arrest.
  • Describe the safety concerns and disadvantages to administering thrombolytics in the setting of cardiac arrest.
  • Appraise the selection of thrombolytic agent in the setting of cardiac arrest.

Speaker Disclosures

Dr. Megan Rech, a speaker, has received grant/research support from Spero pharmaceutics. All other speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose.

Modified on May 30, 2023